Dr. Jonathan W. Goldman
Claim this profileUCLA / Jonsson Comprehensive Cancer Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
19 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
RET positive
2Lung Cancer
Stage IV
RET positive
Stage III
Affiliated Hospitals
Clinical Trials Jonathan W. Goldman is currently running
Talazoparib + Temozolomide
for Small Cell Lung Cancer
This trial studies how effective talazoparib and temozolomide are for treating patients with extensive-stage small cell lung cancer that has come back after initial chemotherapy. Talazoparib stops cancer cells from repairing their DNA, while temozolomide kills or stops the growth of these cells. The combination may work better than either drug alone.
Recruiting1 award Phase 219 criteria
LYL797
for Breast and Lung Cancer
This trial is testing a new treatment called LYL797, which uses modified immune cells to target and kill hard-to-treat breast and lung cancer cells. The study aims to find a safe dose and see how well it works in patients whose cancers have not responded to other treatments.
Recruiting1 award Phase 17 criteria
More about Jonathan W. Goldman
Clinical Trial Related5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Jonathan W. Goldman has experience with
- Temozolomide
- Pembrolizumab
- UCT-03-008
- Necitumumab
- Trastuzumab
- Osimertinib
Breakdown of trials Jonathan W. Goldman has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan W. Goldman specialize in?
Jonathan W. Goldman focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Jonathan W. Goldman currently recruiting for clinical trials?
Yes, Jonathan W. Goldman is currently recruiting for 10 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Jonathan W. Goldman has studied deeply?
Yes, Jonathan W. Goldman has studied treatments such as Temozolomide, Pembrolizumab, UCT-03-008.
What is the best way to schedule an appointment with Jonathan W. Goldman?
Apply for one of the trials that Jonathan W. Goldman is conducting.
What is the office address of Jonathan W. Goldman?
The office of Jonathan W. Goldman is located at: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA / Jonsson Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.